Financials
Financial year 2025
PHARMA LEYENS from Liège, company number BE0695786740, closed financial year 2025 with a result of € -34,190 after tax. For that financial year PHARMA LEYENS recorded a gross margin of € 113,575 and equity of € 43,537. Compared with financial year 2024, the result moved from € 5,719 to € -34,190. The company made a loss. The buffer shrank hard: equity is 60 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 43,537
▼ 60% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -34,190
▼ still € 5,719 profit in 2024
Profit after tax over the fiscal year.
€ 46,204
▲ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 23,537.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 94,461
▼ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 17,354
▼ 41% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 131,160
▼ 33% vs 2024
€ 41,800 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 99,974
▼ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,411
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 136,138 | € 153,122 | € 158,260 | € 113,575 | ▼ 28% |
| Profit after taxes | € 25,836 | € 12,838 | € 5,719 | € -34,190 | ▼ € 39,909 |
| Equity | € 89,170 | € 102,008 | € 107,727 | € 43,537 | ▼ 60% |
| Total debts | € 238,399 | € 261,119 | € 334,979 | € 267,819 | ▼ 20% |
| Cash | € 49,971 | € 24,084 | € 40,558 | € 46,204 | ▲ 14% |
| Retained profit | € 69,170 | € 82,008 | € 87,727 | € 23,537 | ▼ 73% |
| Dividend | € 0 | € 0 | € 0 | € 30,000 | |
| Bank debt | € 168,824 | € 189,534 | € 195,567 | € 131,160 | ▼ 33% |
| Balance sheet total | € 327,569 | € 363,127 | € 442,706 | € 311,356 | ▼ 30% |
Key figures of PHARMA LEYENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA LEYENS?
What happened at PHARMA LEYENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 34,190 (▼ € 39,909 vs 2024). Source: NBB ↗
- New establishment in Liège. KBO
- Lucie LEYENS became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 25,836 profit in 2022 to € 34,190 loss in 2025.
Paid € 14,283 in corporate taxes since 2022.
Best year ever: 2022, with € 25,836 profit.
Paid out € 30,000 in dividends to the owners in total.
Management
Behind PHARMA LEYENS is Lucie LEYENS. Lucie LEYENS is also behind LEYENS MANAGEMENT.
Directors
According to the 2025 annual accounts
since 2018
Establishments
Establishment units
Physical locations of this company
Rue Saint-Laurent 160
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0695.786.740
- VAT number
- BE 0695.786.740
- Registered office
- Rue Saint-Laurent 160, 4000 Liège
- Names & denominations
- PHARMA LEYENS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 May 2018
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Vervaardiging van overige farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels